Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read By Dr. Bradley McGregor | Published April 02, 2025Renal cell cancer (RCC) treatment continues to evolve, and Tivozanib (TIVO) is…
MOASC Awards $25,000 Research Grant from AVEO Oncology to Dr. Peter Zang, MD of City of Hope 2025 Cary Presant, MD Investigator Award Prostate 4 Mins Read Introduction: A Milestone Achievement for Dr. Peter ZangPeter Zang, MD, a second-year fellow at City of Hope, has reached a…
